These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17486460)

  • 1. Comparative study of two insulin regimes in pregnancy complicated by diabetes mellitus.
    Nor Azlin MI; Nor NA; Sufian SS; Mustafa N; Jamil MA; Kamaruddin NA
    Acta Obstet Gynecol Scand; 2007; 86(4):407-8. PubMed ID: 17486460
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy.
    Smith JG; Manuck TA; White J; Merrill DC
    Am J Perinatol; 2009 Jan; 26(1):57-62. PubMed ID: 18979406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of diabetes in pregnancy.
    Balaji V; Seshiah V
    J Assoc Physicians India; 2011 Apr; 59 Suppl():33-6. PubMed ID: 21823253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin.
    Di Cianni G; Volpe L; Ghio A; Lencioni C; Cuccuru I; Benzi L; Del Prato S
    Diabetes Care; 2007 Apr; 30(4):e11. PubMed ID: 17392526
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of insulin analogues in pregnancy.
    Lambert K; Holt RI
    Diabetes Obes Metab; 2013 Oct; 15(10):888-900. PubMed ID: 23489521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
    Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
    Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of declining insulin requirements during pregnancy in patients with pre-gestational gestational diabetes mellitus.
    Ram M; Feinmesser L; Shinar S; Maslovitz S
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():148-152. PubMed ID: 28628847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus.
    Persson B; Swahn ML; Hjertberg R; Hanson U; Nord E; Nordlander E; Hansson LO
    Diabetes Res Clin Pract; 2002 Nov; 58(2):115-21. PubMed ID: 12213353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic Control and Pregnancy Outcomes in Women with Type 2 Diabetes Treated with Oral Hypoglycemic Agents.
    Feghali MN; Caritis SN; Catov JM; Scifres CM
    Am J Perinatol; 2017 Jun; 34(7):697-704. PubMed ID: 27984840
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin in pregnancy: guidelines that can be implement.
    Chowdhury S; Chakraborty PP
    J Indian Med Assoc; 2013 Nov; 111(11):766-9. PubMed ID: 24968487
    [No Abstract]   [Full Text] [Related]  

  • 13. The potential for the use of insulin lispro in pregnancy complicated by diabetes.
    Carr KJ; Lindow SW; Masson EA
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):323-9. PubMed ID: 16801307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis.
    Pollex E; Moretti ME; Koren G; Feig DS
    Ann Pharmacother; 2011 Jan; 45(1):9-16. PubMed ID: 21205954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of pre-gestational diabetes mellitus diagnosed during pregnancy and the effects on pregnancy outcomes].
    Wei YM; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):227-232. PubMed ID: 28441837
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
    Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of insulin detemir in pregnancy: a retrospective case series.
    Shenoy VV; Cook SJ; Parry AF; McIntyre HD
    Diabet Med; 2012 Jul; 29(7):958-9. PubMed ID: 22248154
    [No Abstract]   [Full Text] [Related]  

  • 18. Pregnancy and Neonatal Outcomes in Gestational Diabetes Treated with Regular Insulin or Fast-Acting Insulin Analogues.
    You JY; Choi SJ; Roh CR; Kim JH; Oh SY
    Gynecol Obstet Invest; 2016; 81(3):232-7. PubMed ID: 26474335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gestational diabetes: insulin therapy in case of normal glycemia?].
    Schäfer-Graf U
    Dtsch Med Wochenschr; 2008 Feb; 133(6):264. PubMed ID: 18236359
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes.
    Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE
    Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.